Medical Electrocardiogram (ECG) Telemetry Equipment Market Report 2025

The medical electrocardiogram (ECG) telemetry equipment market size has grown rapidly in recent years. It will grow from $1.12 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth during the historic period can be attributed to the rising prevalence of cardiovascular diseases, increased adoption of remote patient monitoring, growing demand for continuous cardiac monitoring, and the expansion of healthcare infrastructure.

The medical electrocardiogram (ECG) telemetry equipment market size is expected to see rapid growth in the next few years. It will grow to $1.89 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth during the forecast period can be attributed to the rising demand for wearable electrocardiogram devices, increasing healthcare expenditure in emerging economies, a growing focus on home-based healthcare, the increasing incidence of lifestyle-related disorders, and heightened demand for personalized healthcare solutions. Key trends expected during the forecast period include technological advancements in wireless telemetry, innovations in compact ECG monitoring devices, developments in AI-based ECG analysis, investments in remote patient management platforms, and ongoing research and development in smart biosensors.

The rising prevalence of cardiovascular diseases is expected to drive the growth of the medical electrocardiogram (ECG) telemetry equipment market in the coming years. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels, including coronary heart disease, heart failure, stroke, and hypertension. This increase is largely linked to poor dietary habits, as excessive intake of saturated fats, trans fats, added sugars, and sodium contributes to high blood pressure, obesity, and elevated cholesterol levels - key risk factors for heart-related conditions. Medical ECG telemetry equipment aids in diagnosing cardiovascular diseases by enabling continuous, real-time heart monitoring, which is vital for the early detection of arrhythmias and other cardiac conditions. By remotely transmitting ECG data to healthcare providers, it reduces diagnostic delays, supports timely intervention, and improves patient outcomes. For example, in December 2023, the Australian Institute of Health and Welfare, a government agency in Australia, reported that doctor-certified deaths due to coronary heart disease (CHD) rose from 14,100 in 2021 to 14,900 in 2022. Consequently, the increasing incidence of cardiovascular diseases is fueling the growth of the medical ECG telemetry equipment market.

Leading companies in the medical ECG telemetry equipment market are developing technologically advanced solutions, such as mobile cardiac telemetry systems, to facilitate real-time, remote heart monitoring and improve early detection of arrhythmias. Mobile cardiac telemetry systems are wearable devices that continuously monitor a patient’s heart activity and transmit data to healthcare providers for immediate analysis. For instance, in April 2022, ZOLL Medical Corporation, a US-based medical device company, launched the Arrhythmia Management System (AMS), an advanced mobile cardiac telemetry (MCT) solution. The AMS provides continuous, real-time ECG monitoring outside clinical settings, enabling faster detection and intervention for cardiac arrhythmias. The system includes advanced analytics, wireless data transmission, and cloud-based reporting, allowing healthcare providers to review patient data promptly. This technology improves patient care by minimizing delays in diagnosis and treatment, especially for individuals at risk of life-threatening arrhythmias.

In June 2024, Anumana Inc., a US-based AI-driven health technology company, partnered with InfoBionic.AI Inc. to advance AI-powered cardiac monitoring. The collaboration seeks to combine advanced ECG-AI algorithms with remote cardiac telemetry technology to enable earlier and more accurate detection of heart conditions, improving patient outcomes through AI-enhanced remote monitoring. InfoBionic.AI Inc., also based in the US, specializes in AI-powered medical ECG telemetry solutions for remote cardiac monitoring.

Major players in the medical electrocardiogram (ecg) telemetry equipment market are Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Philips Healthcare, Boston Scientific Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Nihon Kohden Corporation, CONTEC Medical Systems Co. Ltd., Natus Medical Incorporated, iRhythm Technologies Inc., Schiller AG, Edan Instruments Inc., BPL Medical Technologies Pvt. Ltd., AliveCor Inc., Innomed Medical Inc., Bionet Co. Ltd., Cardioline S.p.A., Aerotel Medical Systems Ltd., CompuMed Inc.

North America was the largest region in the medical electrocardiogram (ECG) telemetry equipment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in medical electrocardiogram (ECG) telemetry equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the medical electrocardiogram (ECG) telemetry equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Medical electrocardiogram (ECG) telemetry equipment is a remote monitoring system designed to continuously track a patient’s heart activity in real-time. It wirelessly transmits ECG signals to a central monitoring station, enabling healthcare providers to quickly detect and respond to abnormal heart rhythms. This technology enhances cardiac care by facilitating early diagnosis and timely intervention, particularly for patients at risk of arrhythmias or other cardiac events.

The primary types of medical ECG telemetry equipment include resting ECG devices, stress ECG devices, and others. Resting ECG devices are used to record the heart’s electrical activity while the patient is at rest, typically lying down, to identify cardiac abnormalities such as arrhythmias, myocardial infarction, and other heart conditions. These devices employ a variety of technologies, including analog ECG devices, digital ECG devices, cloud-based ECG solutions, mobile ECG monitoring systems, and wireless transmission technologies. Connectivity options include wired ECG systems, wireless ECG systems, Bluetooth-enabled devices, Wi-Fi-connected monitors, and satellite communication-based ECG systems. They are widely applied in cardiology, critical care, emergency care, telemedicine, and remote patient monitoring, serving end users such as hospitals, diagnostic laboratories, home care settings, ambulatory surgical centers, and nursing homes.

The medical electrocardiogram telemetry equipment market research report is one of a series of new reports that provides medical electrocardiogram telemetry equipment market statistics, including medical electrocardiogram telemetry equipment industry global market size, regional shares, competitors with a medical electrocardiogram telemetry equipment market share, detailed medical electrocardiogram telemetry equipment market segments, market trends and opportunities, and any further data you may need to thrive in the medical electrocardiogram telemetry equipment industry. This medical electrocardiogram telemetry equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical electrocardiogram (ECG) telemetry equipment market consists of revenues earned by entities by providing services such as real-time cardiac data integration, device installation and calibration, continuous heart rhythm surveillance, alert-based clinician notifications, and remote troubleshooting support. The market value includes the value of related goods sold by the service provider or included within the service offering. The medical electrocardiogram (ECG) telemetry equipment market also includes sales of rechargeable electrode patches, multi-lead monitoring kits, mobile data relay units, modular telemetry carts, and battery-powered electrocardiogram signal processors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.